Top Markets
Coin of the day
Allena Pharmaceuticals, Inc. Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc.

ALNAQ
株式のランク #42825
Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on... Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on unearthing, developing, and marketing oral enzyme therapies. These treatments are devised to assist patients in the United States afflicted by uncommon and serious metabolic as well as renal conditions. Central to its pipeline is ALLN-346, an innovative enzyme designed to degrade urate, targeting hyperuricemia and gout in individuals with advanced chronic kidney disease. The company, which commenced operations in 2011 and has its main office in Newton, Massachusetts, made headlines on September 2, 2022, by seeking voluntary reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
株価
$0.000001
最終同期: 2023-12-13
時価総額
$23.51
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Allena Pharmaceuticals, Inc. (ALNAQ)

カテゴリー

Allena Pharmaceuticals, Inc.(ALNAQ)の配当利回りの履歴
Allena Pharmaceuticals, Inc.(銘柄コード: ALNAQ)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Allena Pharmaceuticals, Inc.(ALNAQ)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)